Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Autoimmune Diseases”

398 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 398 results

Testing effectiveness (Phase 2)Study completedNCT02633163
What this trial is testing

Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)

Who this might be right for
Systemic Lupus Erythematosus
Medical University of South Carolina 81
Testing effectiveness (Phase 2)Study completedNCT04083014
What this trial is testing

Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic AnemiaAutoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
Peking Union Medical College Hospital 33
Not applicableLooking for participantsNCT06503224
What this trial is testing

An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
The First Affiliated Hospital of University of Science and Technology of China 18
Early research (Phase 1)Looking for participantsNCT07403097
What this trial is testing

Study of CD19 CAR-T Therapy for Refractory SLE

Who this might be right for
Systemic Lupus Erythematosus
Chongqing Precision Biotech Co., Ltd 18
Large-scale testing (Phase 3)Study completedNCT06764160
What this trial is testing

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG

Who this might be right for
Generalized Myasthenia Gravis (gMG)Refractory gMG
Alexion Pharmaceuticals, Inc. 15
Large-scale testing (Phase 3)UnknownNCT01974518
What this trial is testing

Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus

Who this might be right for
Pemphigus
Uprety Shraddha 20
Not applicableStudy completedNCT04687332
What this trial is testing

IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases

Who this might be right for
Neurological Autoimmune Diseases
University Medical Center Mainz 32
Early research (Phase 1)Enrolling By InvitationNCT07038447
What this trial is testing

KITE-363 in Participants With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more
Kite, A Gilead Company 52
Testing effectiveness (Phase 2)Looking for participantsNCT06947460
What this trial is testing

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension
Beijing GoBroad Hospital 45
Very early researchLooking for participantsNCT07174843
What this trial is testing

An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases

Who this might be right for
Idiopathic Inflammatory Myopathies(IIM)Immune Thrombocytopenia(ITP)Systemic Lupus Erythematosus(SLE)
Shanghai Cell Therapy Group Co.,Ltd 20
Early research (Phase 1)Looking for participantsNCT07331467
What this trial is testing

Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE

Who this might be right for
Systemic Lupus Erythematosus
Chongqing Precision Biotech Co., Ltd 18
Early research (Phase 1)Looking for participantsNCT07361094
What this trial is testing

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178431
What this trial is testing

MB-CART2019.1 in Refractory Multiple Sclerosis

Who this might be right for
Multiple SclerosisCAR T Cell Therapy
Miltenyi Biomedicine GmbH 26
Not applicableLooking for participantsNCT06973356
What this trial is testing

Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Anhui Provincial Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT06189157
What this trial is testing

MB-CART19.1 in Refractory SLE

Who this might be right for
SLE - Systemic Lupus Erythematosus
Miltenyi Biomedicine GmbH 29
Testing effectiveness (Phase 2)WithdrawnNCT01236456
What this trial is testing

High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Stony Brook University
Early research (Phase 1)Looking for participantsNCT06941129
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusSystemic Sclerosis (SSc)Inflammatory Myopathy+3 more
Institute of Hematology & Blood Diseases Hospital, China 12
Not applicableWithdrawnNCT03003143
What this trial is testing

Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients

Who this might be right for
Autoimmune Encephalopathy
Seoul National University Hospital
Not applicableLooking for participantsNCT06373081
What this trial is testing

Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic Sclerosis+3 more
Shanghai Changzheng Hospital 6
Large-scale testing (Phase 3)UnknownNCT02877212
What this trial is testing

Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 75
Load More Results